1 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 2 Saddoughi SA,Reinersman JM,Zhukov YO,et al.Survival after surgical resection of stage IV esophageal cancer[J].Ann Thorac Surg,2017,103(1):261-266. 3 Wohrer SS,Raderer M,Hejna M.Palliative chemotherapy for advanced gastric cancer[J].Ann Oncol,2004,15(11):1585-1595. 4 Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):177-193. 5 Holohan C,Van Schaeybroeck S,Longley DB,et al.Cancer drug resistance:an evolving paradigm[J].Nat Rev Cancer,2013,13(10):714-726. 6 Wilusz JE,Sunwoo H,Spector DL.Long noncoding RNAs:functional surprises from the RNA world[J].Genes Development,2009,23(13):1494-1504. 7 Ponting CP,Oliver PL,Reik W.Evolution and functions of long noncoding RNAs[J].Cell,2009,136(4):629-641. 8 Beermann J,Piccoli MT,Viereck J,et al.Non-coding RNAs in development and disease:Background,mechanisms,and therapeutic approaches[J].Physiol Rev,2016,96(4):1297-1325. 9 Martens JA,Laprade L,Winston F.Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene[J].Nature,2004,429(6991):571-574. 10 Majidinia M,Yousefi B.Long non-coding RNAs in cancer drug resistance development[J].DNA Repair(Amst),2016,45:25-33. 11 Verstraelen J,Reichl S.Multidrug resistance-associated protein(MRP1,2,4 and 5)expression in human corneal cell culture models and animal corneal tissue[J].Mol Pharm,2014,11(7):2160-2171. 12 Lan WG,Xu DH,Xu C,et al.Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells[J].Oncol Rep,2016,36(1):263-270. 13 Zhang XW,Bu P,Liu L,et al.Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance[J].Biochem Biophys Res Commun,2015,462(3):227-232. 14 Wang Y,Zhang D,Wu K,et al.Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines[J].Mol Cell Biol,2014,34(17):3182-3193. 15 王颖.长链非编码RNA DMTF1v4(NR_024549)在胃癌多药耐药中的作用及机制研究[D].陕西:第四军医大学,2012:1-145. 16 Ma Y,Yang Y,Wang F,et al.Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha[J].Gut,2016,65(9):1494-1504. 17 Salmena L,Poliseno L,Tay Y,et al.A ceRNA hypothesis:the Rosetta stone of a hidden RNA language?[J].Cell,2011,146(3):353-358. 18 Qi X,Zhang DH,Wu N,et al.ceRNA in cancer:possible functions and clinical implications[J].J Med Genet,2015,52(10):710-718. 19 张哲.长链非编码RNA分子UCA1介导胃癌多药耐药的机制研究[D].陕西:第四军医大学,2015:1-93. 20 Fang Q,Chen X,Zhi X.Long non-coding RNA(LncRNA)urothelial carcinoma associated 1(UCA1)increases multi-drug resistance of gastric cancer via downregulating miR-27b[J].Med Sci Monit,2016,22:3506-3513. 21 Bian Z,Jin L,Zhang J,et al.LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J].Sci Rep,2016,6:23892. 22 Liang WC,Fu WM,Wong CW,et al.The LncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer[J].Oncotarget,2015,6(26):22513-22525. 23 Yue B,Cai D,Liu C,et al.Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer[J].Mol Ther,2016,24(12):2064-2077. 24 Tsuruo T,Naito M,Tomida A,et al.Molecular targeting therapy of cancer:drug resistance,apoptosis and survival signal[J].Cancer Sci,2003,94(1):15-21. 25 Shang C,Guo Y,Zhang J,et al.Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer[J].Cancer Chemother Pharmacol,2016,77(5):1061-1067. 26 Tsang WP,Wong TW,Cheung AH,et al.Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR[J].RNA,2007,13(6):890-898. 27 Radisky DC.Epithelial-mesenchymal transition[J].J Cell Sci,2005,118(Pt 19):4325-4326. 28 Xia H,Hui KM.MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics[J].Cancer Gene Ther,2012,19(11):723-730. 29 Han Y,Ye J,Wu D,et al.LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition[J].BMC Cancer,2014,14:932. 30 倪瑶瑶.下调HOTAIR表达对结直肠癌及其癌干细胞侵袭、转移和致瘤性的影响[D].南京:东南大学,2015:1-65. 31 Ding J,Li D,Gong M,et al.Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer[J].Onco Targets Ther,2014,7:1625-1630. 32 Lee H,Kim C,Ku JL,et al.A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells[J].Mol Cells,2014,37(7):540-546. 33 Xiong W,Jiang YX,Ai YQ,et al.Microarray analysis of long non-coding RNA expression profile associated with 5-Fluorouracil-based chemoradiation resistance in colorectal cancer cells[J].Asian Pac J Cancer Prev,2015,16(8):3395-3402. 34 Sun QL,Zhao CP,Wang TY,et al.Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing[J].Gene,2015,572(1):79-86. 35 Zhou XL,Wang WW,Zhu WG,et al.High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy[J].Mol Carcinog,2016,55(12):2095-2105. 36 Jiang L,Wang W,Li G,et al.High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma[J].Cancer Chemother Pharmacol,2016,78(2):333-339. 37 Tong YS,Zhou XL,Wang XW,et al.Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma[J].J Transl Med,2014,12:233. |